Published in J Clin Microbiol on November 01, 2003
H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut (2004) 4.66
Functional and molecular surveillance of Helicobacter pylori antibiotic resistance in Kuala Lumpur. PLoS One (2014) 0.88
Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines. Ann Clin Microbiol Antimicrob (2004) 0.88
NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA (1994) 8.57
Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group. Gut (1997) 2.61
Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol (1991) 2.26
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Resistance of Helicobacter pylori to antibiotics. Aliment Pharmacol Ther (1997) 2.01
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother (1999) 1.73
Diagnosis of Campylobacter pylori infections: the "gold standard" and the alternatives. Rev Infect Dis (1990) 1.53
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter (1996) 1.27
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother (1998) 1.24
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Recommendations for susceptibility tests on fastidious organisms and those requiring special handling. J Antimicrob Chemother (2001) 1.20
Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol (1996) 1.16
Exposure to metronidazole in vivo readily induces resistance in Helicobacter pylori and reduces the efficacy of eradication therapy in mice. Antimicrob Agents Chemother (1999) 1.14
Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands. Emerg Infect Dis (1997) 1.12
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods. Pathology (1997) 1.09
Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur J Clin Microbiol Infect Dis (1998) 1.00
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.00
Characterization of clinical isolates of Helicobacter pylori in Singapore. Microbios (1998) 0.98
Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients. Ir J Med Sci (1993) 0.97
Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut (1996) 0.93
Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy. Eur J Gastroenterol Hepatol (1999) 0.88
Discrepancies between E-test and agar dilution methods for testing metronidazole susceptibility of Helicobacter pylori. J Clin Microbiol (1998) 0.87
Improving the success of culturing Helicobacter pylori from gastric biopsies. Microbios (1998) 0.84
Respiratory protein-generated reactive oxygen species as an antimicrobial strategy. Nat Immunol (2007) 2.02
Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal. Eur J Cancer (2008) 1.65
Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey. Gastrointest Endosc (2007) 1.55
Validation of structured scoring using the LA classification for esophagitis and endoscopically suspected Barrett's esophagus in a tertiary Asian endoscopy center. J Gastroenterol Hepatol (2008) 1.50
Iron-withholding strategy in innate immunity. Immunobiology (2006) 1.45
Helicobacter pylori gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology (2010) 1.31
The ancient origin of the complement system. EMBO J (2004) 1.25
C-reactive protein collaborates with plasma lectins to boost immune response against bacteria. EMBO J (2007) 1.19
Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc (2012) 1.19
Local inflammation induces complement crosstalk which amplifies the antimicrobial response. PLoS Pathog (2009) 1.10
The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (2009) 1.10
SARM inhibits both TRIF- and MyD88-mediated AP-1 activation. Eur J Immunol (2010) 1.08
Determination of critical micelle concentrations and aggregation numbers by fluorescence correlation spectroscopy: aggregation of a lipopolysaccharide. Anal Chim Acta (2005) 1.04
Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. EMBO J (2013) 1.01
Targeting of pro-apoptotic TLR adaptor SARM to mitochondria: definition of the critical region and residues in the signal sequence. Biochem J (2012) 0.99
Effect of biopsies on sensitivity and specificity of ultra-rapid urease test for detection of Helicobacter pylori infection: a prospective evaluation. World J Gastroenterol (2004) 0.99
Evidence for the ancient origin of the NF-kappaB/IkappaB cascade: its archaic role in pathogen infection and immunity. Proc Natl Acad Sci U S A (2006) 0.99
Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res (2010) 0.98
Perturbation of Lipopolysaccharide (LPS) Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS. J Biol Chem (2004) 0.96
Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β. PLoS One (2012) 0.95
The synergy in cytokine production through MyD88-TRIF pathways is co-ordinated with ERK phosphorylation in macrophages. Immunol Cell Biol (2013) 0.94
An evolutionarily conserved 16-kDa thioredoxin-related protein is an antioxidant which regulates the NF-kappaB signaling pathway. Free Radic Biol Med (2006) 0.94
Effect of silver content on the antibacterial and bioactive properties of silver-substituted hydroxyapatite. J Biomed Mater Res A (2013) 0.94
The response of ferritin to LPS and acute phase of Pseudomonas infection. J Endotoxin Res (2005) 0.93
Rapid reprogramming of haemoglobin structure-function exposes multiple dual-antimicrobial potencies. EMBO J (2009) 0.93
Diversity in lectins enables immune recognition and differentiation of wide spectrum of pathogens. Int Immunol (2006) 0.92
Complications of endoscopic retrograde cholangiography in the post-MRCP era: a tertiary center experience. World J Gastroenterol (2005) 0.91
Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model. J Proteomics (2010) 0.91
A novel human tectonin protein with multivalent beta-propeller folds interacts with ficolin and binds bacterial LPS. PLoS One (2009) 0.90
Rational design of green fluorescent protein mutants as biosensor for bacterial endotoxin. Protein Eng (2002) 0.89
Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds. Biomaterials (2010) 0.89
Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue. Biochemistry (2009) 0.89
Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria. BMC Biol (2009) 0.89
Thioredoxin-like 6 protects retinal cell line from photooxidative damage by upregulating NF-kappaB activity. Free Radic Biol Med (2008) 0.87
C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection. J Endotoxin Res (2004) 0.86
Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study. Gastric Cancer (2002) 0.86
Interaction of an artificial antimicrobial peptide with lipid membranes. Biochim Biophys Acta (2008) 0.86
TLR cross-talk confers specificity to innate immunity. Int Rev Immunol (2014) 0.86
Secreted M-ficolin anchors onto monocyte transmembrane G protein-coupled receptor 43 and cross talks with plasma C-reactive protein to mediate immune signaling and regulate host defense. J Immunol (2010) 0.85
Delineation of lipopolysaccharide (LPS)-binding sites on hemoglobin: from in silico predictions to biophysical characterization. J Biol Chem (2011) 0.85
A computational and experimental study of the regulatory mechanisms of the complement system. PLoS Comput Biol (2011) 0.85
CD163 and IgG codefend against cytotoxic hemoglobin via autocrine and paracrine mechanisms. J Immunol (2013) 0.84
Surface localized Heat Shock Protein 20 (HslV) of Helicobacter pylori. Helicobacter (2003) 0.84
Transcriptional regulation of limulus factor C: repression of an NFkappaB motif modulates its responsiveness to bacterial lipopolysaccharide. J Biol Chem (2003) 0.84
The macromolecular assembly of pathogen-recognition receptors is impelled by serine proteases, via their complement control protein modules. J Mol Biol (2008) 0.84
Modular arrangement and secretion of a multidomain serine protease. Evidence for involvement of proline-rich region and N-glycans in the secretion pathway. J Biol Chem (2002) 0.84
Molecular interfaces of the galactose-binding protein Tectonin domains in host-pathogen interaction. J Biol Chem (2010) 0.84
Molecular mechanisms that govern the specificity of Sushi peptides for Gram-negative bacterial membrane lipids. Biochemistry (2006) 0.83
Proteomannans in biofilm of Helicobacter pylori ATCC 43504. Helicobacter (2011) 0.83
The molecular mechanism of interaction between sushi peptide and Pseudomonas endotoxin. Cell Mol Immunol (2006) 0.82
Identification of H. pylori strain specific DNA sequences between two clinical isolates from NUD and gastric ulcer by SSH. World J Gastroenterol (2003) 0.82
Alterations in rdxA and frxA genes and their upstream regions in metronidazole-resistant Helicobacter pylori isolates. Res Microbiol (2006) 0.82
Purification, characterization and bactericidal activities of basic phospholipase A2 from the venom of Agkistrodon halys (Chinese pallas). Biochimie (2008) 0.81
Viper metalloproteinase (Agkistrodon halys pallas) with antimicrobial activity against multi-drug resistant human pathogens. J Cell Physiol (2008) 0.81
Engineering a novel secretion signal for cross-host recombinant protein expression. Protein Eng (2002) 0.81
Prominent role of gamma-glutamyl-transpeptidase on the growth of Helicobacter pylori. World J Gastroenterol (2004) 0.81
Pathophysiological condition changes the conformation of a flexible FBG-related protein, switching it from pathogen-recognition to host-interaction. Biochimie (2011) 0.81
Elucidating the function of an ancient NF-kappaB p100 homologue, CrRelish, in antibacterial defense. Infect Immun (2007) 0.80
Immobilization studies of an engineered arginine-tryptophan-rich peptide on a silicone surface with antimicrobial and antibiofilm activity. ACS Appl Mater Interfaces (2013) 0.80
Lipid-free apolipoprotein A-I exerts an antioxidative role against cell-free hemoglobin. Am J Clin Exp Immunol (2012) 0.80
Stability of randomly amplified polymorphic DNA fingerprinting in genotyping clinical isolates of Helicobacter pylori. World J Gastroenterol (2003) 0.80
Effect of crowding on the conformation of interwound DNA strands from neutron scattering measurements and Monte Carlo simulations. Phys Rev E Stat Nonlin Soft Matter Phys (2010) 0.80
The antimicrobial properties of C-reactive protein (CRP). J Endotoxin Res (2005) 0.79
Imagine a world without cancer. BMC Cancer (2014) 0.79
Sequence and structural diversity in endotoxin-binding dodecapeptides. Biochim Biophys Acta (2003) 0.79
The effects of silver, silicon-containing apatite towards bacteria and cell responses. Biomed Mater (2014) 0.79
In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population. J Clin Gastroenterol (2008) 0.79
Endotoxin detection--from limulus amebocyte lysate to recombinant factor C. Subcell Biochem (2010) 0.79
Immune responses to differentiated forms of Helicobacter pylori in children with epigastric pain. Clin Diagn Lab Immunol (2003) 0.79
Antiadhesive property of microalgal polysaccharide extract on the binding of Helicobacter pylori to gastric mucin. FEMS Immunol Med Microbiol (2007) 0.79
Investigation of a novel artificial antimicrobial peptide by fluorescence correlation spectroscopy: an amphipathic cationic pattern is sufficient for selective binding to bacterial type membranes and antimicrobial activity. Biochim Biophys Acta (2005) 0.79
A female-specific pentraxin, CrOctin, bridges pattern recognition receptors to bacterial phosphoethanolamine. Eur J Immunol (2007) 0.78
Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes. World J Gastroenterol (2004) 0.78
Histidine-mediated pH-sensitive regulation of M-ficolin:GlcNAc binding activity in innate immunity examined by molecular dynamics simulations. PLoS One (2011) 0.77
Serum IgG response to differentiated antigens of Helicobacter pylori. World J Gastroenterol (1998) 0.77
Structural basis for dual-inhibition mechanism of a non-classical Kazal-type serine protease inhibitor from horseshoe crab in complex with subtilisin. PLoS One (2011) 0.77
A novel fluorescent protein-based biosensor for gram-negative bacteria. Appl Environ Microbiol (2002) 0.77
Expression of Lewis(b) blood group antigen in Helicobacter pylori does not interfere with bacterial adhesion property. World J Gastroenterol (2003) 0.77
Validation of four Helicobacter pylori rapid blood tests in a multi-ethnic Asian population. World J Gastroenterol (2005) 0.77
Tandem repeats of Sushi3 peptide with enhanced LPS-binding and -neutralizing activities. Protein Eng (2003) 0.76
Crystallization of a nonclassical Kazal-type Carcinoscorpius rotundicauda serine protease inhibitor, CrSPI-1, complexed with subtilisin. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.76
One step at a time: action mechanism of Sushi 1 antimicrobial peptide and derived molecules. Virulence (2010) 0.75
Metastatic pancreatic cancer presenting as a bleeding duodenal ulcer 30 months after initial diagnosis of duodenal ulcer. Should duodenal ulcers be biopsied or followed up with repeat endoscopy? Acta Gastroenterol Belg (2009) 0.75
Preferential silent survival of intracellular bacteria in hemoglobin-primed macrophages. J Innate Immun (2014) 0.75
Application of cell-free hemolymph of horseshoe crab in antimicrobial drug screening. Curr Pharm Des (2011) 0.75
Use of atomic force microscopy as a tool to understand the action of antimicrobial peptides on bacteria. Methods Mol Biol (2010) 0.75
Recombinant factor C competes against LBP to bind lipopolysaccharide and neutralizes the endotoxicity. J Endotoxin Res (2007) 0.75